España F - Search Results

1

[Immunological and functional levels of protein C in nephrotic syndrome].

Navarro I, Marugán I, España F, Ruiz MA, Sanjuán L, Aznar J, García-Conde J. Navarro I, et al. Among authors: espana f. Sangre (Barc). 1988 Oct;33(5):352-6. Sangre (Barc). 1988. PMID: 2854664 Spanish. No abstract available.

2

[Protein C in neoplastic disease. Effect of chemotherapy on the protein C levels in patients with inoperable lung neoplasms].

Navarro I, Marugán I, España F, Ruiz M, Alberola V, Aznar J, García Conde J. Navarro I, et al. Among authors: espana f. Sangre (Barc). 1988 Oct;33(5):347-51. Sangre (Barc). 1988. PMID: 2854663 Spanish. No abstract available.

3

[Factor XII (Hageman factor) purification and anti-Hageman antibodies production (author's transl)].

España F, Aznar J. España F, et al. Sangre (Barc). 1978;23(4):393-401. Sangre (Barc). 1978. PMID: 705561 Spanish. No abstract available.

4

Interaction of plasma kallikrein with protein C inhibitor in purified mixtures and in plasma.

España F, Estelles A, Griffin JH, Aznar J. España F, et al. Thromb Haemost. 1991 Jan 23;65(1):46-51. Thromb Haemost. 1991. PMID: 1850876

5

Assay of protein C in human plasma: comparison of amidolytic, coagulation, and immunochemical assays.

España F, Estellés A, Aznar J, Gilabert J. España F, et al. Thromb Res. 1986 Dec 15;44(6):771-82. doi: 10.1016/0049-3848(86)90023-x. Thromb Res. 1986. PMID: 3798419

6

Evaluation of two functional assays for protein C inhibitor/plasminogen activator inhibitor-3 activity.

España F, Hendl S, Gilabert J, Estellés A, Aznar J. España F, et al. Thromb Res. 1993 Jun 1;70(5):375-84. doi: 10.1016/0049-3848(93)90079-4. Thromb Res. 1993. PMID: 8397450

7

Quantification of circulating activated protein C in human plasma by immunoassays--enzyme levels are proportional to total protein C levels.

Espana F, Zuazu I, Vicente V, Estellés A, Marco P, Aznar J. Espana F, et al. Thromb Haemost. 1996 Jan;75(1):56-61. Thromb Haemost. 1996. PMID: 8713780

8

The influence of chemotherapy on plasma coagulation and fibrinolytic systems in lung cancer patients.

Ruiz MA, Marugan I, Estellés A, Navarro I, España F, Alberola V, San Juan L, Aznar J, Garcia-Conde J. Ruiz MA, et al. Among authors: espana f. Cancer. 1989 Feb 15;63(4):643-8. doi: 10.1002/1097-0142(19890215)63:4<643::aid-cncr2820630407>3.0.co;2-j. Cancer. 1989. PMID: 2492447

9

Functional diagnosis of activated protein C resistance in patients with antiphospholipid antibodies.

Aznar J, Villa P, España F. Aznar J, et al. Among authors: espana f. Clin Appl Thromb Hemost. 1999 Apr;5(2):139-40. Clin Appl Thromb Hemost. 1999. PMID: 10725996 No abstract available.

10

Determination of total, free and complexed protein S in plasma by ELISA, and comparison with a standard electroimmunoassay.

España F, Hendl S, Aznar J, Gilabert J, Estellés A. España F, et al. Thromb Res. 1991 Jun 15;62(6):615-24. doi: 10.1016/0049-3848(91)90366-5. Thromb Res. 1991. PMID: 1833853

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

185 results

Search Page

Filters